A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

NCT05667142 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Generalized Tonic-Clonic Seizures

Interventions

DRUG: XEN1101
DRUG: Placebo

Sponsor

Xenon Pharmaceuticals Inc.

Collaborators

[object Object]